4
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Characterization of (3H)-Spiperone Binding to Alpha1 - Adrenergic Receptors in a Smooth Muscle Cell Line

, &
Pages 335-348 | Published online: 26 Sep 2008

References

  • Norris J S, Gorski J, Kohler P O. Androgen receptors in a Syrian hamster ductus deferens tumor cell line. NATURE 1974; 248: 422–424
  • Norris J S, Garmer D J, Brown F, Popovich K, Cornet L E. Characteristics of an adenylate cyclase coupled β2-adrenergic receptor in a smooth muscle tumor cell line. J RECEPTOR RES 1983; 3: 623–645
  • Cornett L E, Ball D W, Norris J S. α1-adrenergic receptors of a smooth muscle cell line: guanine nucleotides do not regulate agonist affinities. J RECEPTOR RES 1982; 2: 601–615
  • Cornett L E, Norris J S. Characterization of the α1-adrenergic subtype in a smooth muscle cell line. J BIOL CHEM 1982; 257: 694–697
  • Lacovic Z, Relja M. Evidence for a widely distributed peripheral dopaminergic system. FEDERATION PROC 1983; 42: 3000–3004
  • Relja M, Lackovic Z, Neff M H. Evidence for the presence of dopaminergic receptors in vas deferens. LIFE SCIENCES 1982; 31: 2571–2575
  • Seeman P. Brain dopamine receptors. PHARMACOL REV 1981; 32: 229–313
  • List S J, Seeman P. Resolution of dopamine and serotonin receptor components of (3H) spiperone binding to rat brain regions. PROC NATL ACAD SCI 1981; 78: 2620–2624
  • Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. ANAL BIOCHEM 1973; 72: 248–254
  • Munson P J, Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. ANAL BIOCHEM 1980; 107: 220–239
  • Delean A, Munson P J, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. AM J PHYSIOL 1978; 235: E97–E102
  • Cheng Y, Prusoff W H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. BIOCHEM PHARMACOL 1973; 22: 2099–2108
  • Leysen J E, Gommeren W, Laduron P M. Spiperone: a ligand of choice for neuroleptic receptors. BIOCHEMICAL PHARMACOL 1978; 27: 307–316
  • Laudron P M. Criteria for receptor sites in binding studies. BIOCHEM PHARMACOL 1984; 33: 833–839
  • Peroutka S J, U'Prichard D C, Greenberg D A, Snyder S H. Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. NEUROPHARMACOL 1977; 16: 540–556
  • Leysen J E, Awouters F, Kennis L, Laudron P M, Vandenberk J, Janssen P AJ. Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors. LIFE SCIENCES 1981; 28: 1015–1022
  • Andorn A C, Maquire M E. (3H) Spiroperidol binding in rat striatum: Two high-affinity sites of differing selectivities. J NEUROCHEM 1980; 35: 1105–1113
  • Morgan D G, Marcusson J G, Finch C E. Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H) spiperone. LIFE SCIENCES 1984; 34: 2507–2514
  • Hamblin M W, Leff S E, Creese I. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. BIOCHEM PHARMACOL 1984; 33: 877–887
  • Withy R M, Mayer R J, Strange P G. Use of (3H) spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus. J NEUROCHEM 1981; 37: 1144–1154
  • Greenberg D A, Snyder S H. Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha-noradrenergic receptors in rat brain membranes. MOL PHARMACOL 1978; 14: 38–49

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.